Socio-economic disparities drive the prevalence of non-alcoholic Fatty Liver Disease (NAFLD) among teenagers in the United States

被引:0
|
作者
Younossi, Zobair [1 ,2 ,3 ]
Paik, James [1 ,2 ,4 ]
Zelber-Sagi, Shira [5 ]
Lazarus, Jeffrey [6 ]
Golabi, Pegah [1 ,2 ,7 ,8 ]
Deavila, Leyla [9 ]
Price, Jillian [9 ]
Ong, Janus [10 ]
Alqahtani, Saleh [11 ]
Henry, Linda [1 ,2 ,3 ,8 ]
机构
[1] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
[2] Inova Hlth Syst, Inova Med, Falls Church, VA USA
[3] Global NASH Council, Wahington, DC USA
[4] Global NASH Council, Falls Church, VA USA
[5] Univ Haifa, Sch Publ Hlth, Haifa, Israel
[6] Univ Barcelona, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain
[7] Global NASH Council, Washington, DC USA
[8] Inova Fairfax Med Campus, Ctr Liver Dis, Dept Med, Falls Church, VA USA
[9] Inova Med, Inova Hlth Syst, Beatty Liver & Obes Res Program, Falls Church, VA USA
[10] Univ Philippines, Coll Med, Manila, Philippines
[11] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-122
引用
收藏
页码:S861 / S861
页数:1
相关论文
共 50 条
  • [41] Antiepileptic drugs and non-alcoholic fatty liver disease (NAFLD)
    Waldmann, M
    Sturm, W
    Naser, A
    Unterberger, I
    Trinka, E
    Bauer, G
    Lechleitner, M
    Luef, G
    EPILEPSIA, 2004, 45 : 161 - 162
  • [42] Diagnosis and management of non-alcoholic fatty liver disease (NAFLD)
    Byrne, C. D.
    POSTGRADUATE MEDICAL JOURNAL, 2018, 94 : A2 - A2
  • [43] Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
    Rong, Li
    Zou, Junyan
    Ran, Wei
    Qi, Xiaohong
    Chen, Yaokai
    Cui, Hongjuan
    Guo, Jinjun
    FRONTIERS IN ENDOCRINOLOGY, 2023, 13
  • [44] Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
    Tomasiewicz, Krzysztof
    Flisiak, Robert
    Halota, Waldemar
    Jaroszewicz, Jerzy
    Lebensztejn, Dariusz
    Lisik, Wojciech
    Malkowski, Piotr
    Pawlowska, Malgorzata
    Piekarska, Anna
    Simon, Krzysztof
    Tronina, Olga
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 4 (03) : 153 - 157
  • [45] Non-Alcoholic Fatty Liver Disease (NAFLD) Management in the Community
    Park, Yongsoo
    Ko, Kyung Soo
    Rhee, Byoung Doo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [46] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND RESPIRATORY FUNCTIONS
    Ozkarafakili, Mufide Arzu
    Ga, Salih Bo
    Ozguven, M. Banu Yilmaz
    RESPIROLOGY, 2018, 23 : 198 - 198
  • [47] Non-alcoholic Fatty Liver Disease Diagnosis and Therapy of NAFLD
    Canbay, Ali
    Lammert, Frank
    Geier, Andreas
    INTERNIST, 2021, 62 (05): : 485 - 485
  • [48] Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt
    Tomah, Shaheen
    Hamdy, Osama
    Abuelmagd, Megahed M.
    Hassan, Attia H.
    Alkhouri, Naim
    Al-Badri, Marwa R.
    Gardner, Hannah
    Eldib, Ahmed H.
    Eid, Elsayed A.
    BMJ OPEN GASTROENTEROLOGY, 2021, 8 (01):
  • [49] High Prevalence of Hepatitis B Virus Susceptibility Among Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)
    Kolli, Himabindu
    Patil, Rashmee
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S996 - S996
  • [50] TRANSPLANT EVALUATION PRACTICES FOR KIDNEY DONORS AND RECIPIENTS WITH HISTORY OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES
    Pang, Alice S.
    Halegoua-De Marzio, Dina
    Sass, David
    Shah, Ashesh
    Singh, Pooja
    Powers, Victoria
    Ryan, Mary
    Fenkel, Jonathan M.
    GASTROENTEROLOGY, 2022, 162 (07) : S1293 - S1293